Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Regression of ocular neovascularization by periocular PEDF gene therapy

May 4, 2004

CpG ODN 1826 activates uveitogenic T-cells in mice

May 4, 2004

Promising topical ciclosporin prodrug against corneal graft rejection

May 3, 2004

PKC-412 improves retinal volume and visual acuity in DME patients

May 3, 2004

Vaccines suggested as an alternative for treating glaucoma

April 30, 2004

Adjunctive therapy with lerdelimumab after phacotrabeculectomy beneficial for IOP

April 30, 2004

Curcumin effective against human retinal endothelial cell proliferation

April 30, 2004

IND clearance for squalamine in neovascular diseases of the eye

April 26, 2004

Phase II trial of INS-37217 Ophthalmic for rhegmatogenous retinal detachment

April 26, 2004

Gatiflo eye drops receive Japanese approval

April 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.